Manage Tickers Link Financial Account

Has my stock been accused of fraud?Join over 160k users who know.

Ticker	Price	Change($)	Change(%)	Shares	Volume	Prev Close	Open	Gain($)	Gain(%)

Ticker	Status	Jurisdiction	Filing Date	CP Start	CP End	CP Loss	Deadline

Ticker	Case Name	Status	CP Start	CP End	Deadline	Settlement Amt

Ticker	Name	Date	Analyst Firm	Up/Down	Target ($)	Rating Change	Rating Current

Hims & Hers Health Raises FY24 Revenue Guidance From $1.20B - $1.23B To $1.37B - $1.40B, Est $1.244B

Author: Benzinga Newsdesk | August 05, 2024 04:20pm

Raises full year 2024 Adjusted EBITDA guidance to a range of $140 million to $155 million

Posted In: HIMS